ANTX Competitors & Alternatives
Compare AN2 Therapeutics Inc with similar stocks in the same industry
Biotechnology
ANTX
Main Stock$5.71
Tradestie Score
51
Market Cap
$35.25M
Analyst Upside
+57.6%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$25.65
|
$256.54M | - | 42 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$10.64
|
$240.89M | - | 55 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.87
|
$231.77M | - | 38 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$9.14
|
$227.00M | - | 59 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$11.74
|
$211.22M | - | 58 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.39
|
$202.58M | - | 50 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.32
|
$199.71M | - | 58 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.99
|
$170.45M | - | 57 | Compare |
More ANTX Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry